Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Best Buy
BBY
$18.1B
| $61.8M | 0.04% |
584,350
-11,300
| -2% | -$1.27M |
|
527
Wyndham Hotels & Resorts
WH
$5.54B
| $61.5M | 0.04% |
797,380
+369,904
| +87% | +$26.5M |
|
528
Okta
OKTA
$23.5B
| $61.5M | 0.04% |
259,074
+173,005
| +201% | +$43M |
|
529
Otis Worldwide
OTIS
$27.2B
| $61.3M | 0.04% |
744,789
+103,695
| +16% | +$9.12M |
|
530
Zurn Elkay Water Solutions
ZWS
$8.13B
| $61.2M | 0.04% |
1,977,062
+1,671,853
| +548% | +$46.8M |
|
|
RAVN
531
DELISTED
Raven Industries Inc
RAVN
| $61.2M | 0.04% |
1,062,188
+895,484
| +537% | +$51.9M |
|
532
PUT
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
| $61.2M | 0.04% |
408,400
| – | – |
|
533
Mondelez International
MDLZ
$82.3B
| $61.1M | 0.04% |
1,050,404
+255,416
| +32% | +$15.9M |
|
534
ASML
ASML
$677B
| $60.9M | 0.04% |
81,725
+21,082
| +35% | +$16.6M |
|
535
Baidu
BIDU
$31.6B
| $60.8M | 0.04% |
395,379
-96,572
| -20% | -$15.9M |
|
|
PLAN
536
DELISTED
Anaplan, Inc.
PLAN
| $60.7M | 0.04% |
996,147
-490,838
| -33% | -$29.2M |
|
537
CALL
Broadcom
AVGO
$1.75T
| $60.6M | 0.04% |
1,250,000
-722,000
| -37% | -$35.1M |
|
538
Realty Income
O
$59.2B
| $60.6M | 0.04% |
963,958
-31,944
| -3% | -$2.16M |
|
539
State Street Health Care Select Sector SPDR ETF
XLV
$45.5B
| $60.4M | 0.04% |
474,158
+72,252
| +18% | +$9.55M |
|
540
CALL
CVS Health
CVS
$119B
| $60.4M | 0.04% |
711,200
-36,600
| -5% | -$3.07M |
|
541
CALL
Pfizer
PFE
$160B
| $60.3M | 0.04% |
1,402,600
+690,100
| +97% | +$30.6M |
|
542
PUT
Dollar General
DG
$27.2B
| $60M | 0.04% |
282,900
+92,100
| +48% | +$20.8M |
|
543
PUT
Ulta Beauty
ULTA
$22.4B
| $59.8M | 0.04% |
165,700
-3,400
| -2% | -$1.23M |
|
544
CALL
Pembina Pipeline
PBA
$28.3B
| $59.4M | 0.04% |
+1,480,000
| New | +$46.7M |
|
545
Airbnb
ABNB
$110B
| $59.4M | 0.04% |
354,131
-147,697
| -29% | -$22.6M |
|
546
CALL
UnitedHealth
UNH
$350B
| $59.4M | 0.04% |
152,000
+59,200
| +64% | +$24.5M |
|
547
PUT
Kraft Heinz
KHC
$30.3B
| $59.2M | 0.04% |
1,608,100
+621,800
| +63% | +$23.4M |
|
548
Globant
GLOB
$1.71B
| $58.9M | 0.04% |
209,679
+28,806
| +16% | +$7.9M |
|
|
WRK
549
DELISTED
WestRock Company
WRK
| $58.9M | 0.04% |
1,182,054
+859,332
| +266% | +$43.4M |
|
|
NATI
550
DELISTED
National Instruments Corp
NATI
| $58.8M | 0.04% |
1,500,088
-77,591
| -5% | -$3.25M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.